Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSulphur burps on Wegovy are caused by slowed gastric emptying. Semaglutide reduces the speed at which food leaves your stomach, giving gut bacteria more time to ferment undigested matter and release hydrogen sulphide gas — the compound responsible for that rotten-egg smell. This is a known gastrointestinal effect of GLP-1 medicines, documented across clinical trials and listed in the medicine's patient information. It tends to be most noticeable in the first few weeks of treatment or after a dose increase, and for most people it settles as the body adjusts. These are common Wegovy side effects rather than a sign that something is wrong, though they can be genuinely unpleasant. Wegovy is a prescription-only medicine; a prescriber assesses suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by activating GLP-1 receptors across several body systems, but the effect most relevant here is on gastric motility. Normally, your stomach contracts rhythmically to push partly digested food into the small intestine. Semaglutide dials that rhythm down. Food lingers. The NHS patient information for semaglutide lists nausea, burping, and bloating as common side effects precisely because this mechanical slowdown is so consistent across users.
The delay itself is intentional from a weight-loss standpoint: you feel full for longer, eat less, and blood-sugar spikes are blunted. The drawback is that partially digested proteins, particularly those rich in sulphur-containing amino acids like cysteine and methionine, spend longer than usual in the stomach and upper gut.
This is the first domino. Everything else follows from here. Understanding whether Wegovy causes sulphur burps really starts with this single physiological fact.
The human gut hosts trillions of bacteria, many of which feed on the proteins and carbohydrates that reach them. When food arrives in larger, more slowly delivered parcels, certain bacteria have more time to ferment. Sulphur-reducing bacteria break down sulphur-containing compounds and release hydrogen sulphide as a byproduct. That gas travels upward and exits as a burp with a distinctive, unpleasant odour.
This process is entirely normal bacterial metabolism, it just becomes amplified when gastric emptying slows. It is not a sign of infection or an allergy to the medicine. You can read a fuller breakdown on our page covering sulphur burps and Wegovy, including which foods trigger the worst episodes.
The same mechanism is why the burps tend to be worse after eating foods with a high sulphur content. Eggs, red meat, brassica vegetables (broccoli, cabbage, Brussels sprouts, cauliflower), garlic, onions, and alcohol all contribute substantially. Some people notice that cutting these foods significantly reduces the problem even without changing their dose.
Wegovy's titration schedule starts at a low dose and rises in stages, each roughly four weeks apart, up to the 2.4mg maintenance dose, and, for eligible patients, to the newer 7.2mg dose following prescriber assessment. Each increase asks the body to adjust again. Gastric emptying slows a little further; bacterial fermentation ramps up; sulphur burps often return even if they had settled.
This pattern means many people experience a predictable cycle: burps appear or worsen for a week or two after moving up a dose, then fade as adaptation occurs. Knowing this rhythm can make it feel more manageable. If you want a clearer picture of timelines, our page on how long sulphur burps last on Wegovy goes through what clinical reports and patient experience suggest.
A practical note: the 12pm cut-off for same-day dispatch is something many patients think about, but the question worth raising with a prescriber first is whether your dose pace is right for you, going too quickly can compound GI symptoms significantly. Slowing down a titration is a legitimate clinical decision, not a failure.
Most sulphur burps require only dietary adjustment and time. But some symptoms warrant clinical input. Severe or persistent stomach pain, particularly pain that radiates through to the back, should be assessed promptly, in January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the MHRA Drug Safety Update on GLP-1 medicines advises seeking urgent medical attention for severe, persistent abdominal pain. Sulphur burps alone are not pancreatitis, but pain alongside them changes the picture.
Dehydration from persistent nausea or vomiting alongside the burps is another reason to make contact early. And if the smell or frequency is significantly affecting your quality of life, that is a legitimate reason to speak to a prescriber about dose timing, titration pace, or dietary strategies. You can find practical tactics on our page about stopping sulphur burps on Wegovy. If you are weighing up treatment options more broadly, the Wegovy overview page covers eligibility, how the medicine works, and what to expect.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.